The Non-Invasive Prenatal Testing (NIPT) market is expected to grow at a moderate CAGR between 2025 and 2032. According to ...
Later pregnancies carry higher risks. Advances in genetic reproductive medicine, like IVF and NIPT are making it possible for ...
When discussing the value of screening for 22q, the authors concluded that, “the PPV of cfDNA for 22q11.2DS is higher and the false positive rate is lower than that associated with other accepted ...
Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics group, today announced the launch of IONA ® Care+, a fully comprehensive non-invasive prenatal ...
The Delhi government's directive banning sending of genetic samples outside the city for advanced prenatal tests has hit ...
BGI Genomics, with its partner Prom-Test Laboratories, celebrates the first localization of the Non-Invasive Prenatal Testing (NIPT) project in Armenia. The project launched in 2024 after a successful ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results